The world’s largest market for pharmaceuticals, USA has always been on Axigen Healthcare’s strategic radar. Planning for our subsidiary, serves the growing need of our products in the market. We plan to strengthen our position in the market by launching complex generics which include specialty therapies. Also, Axigen is planning to strengthened the US presence through acquisition with pharmaceuticals company, who have a good product portfolio in a generic pharmaceuticals and OTC.